Free Trial
OTCMKTS:BGMD

BG Medicine (BGMD) Stock Price, News & Analysis

BG Medicine logo

About BG Medicine Stock (OTCMKTS:BGMD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
601 shs
Average Volume
12,675 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BG Medicine, Inc. was a medical diagnostics company focused on developing and commercializing blood-based tests for cardiovascular disease. Its work centered on biomarkers intended to help physicians assess disease risk, prognosis, and treatment decisions.

The company’s best-known product was the Galectin-3 test, a laboratory assay designed to measure galectin-3, a biomarker associated with cardiac fibrosis and the progression of heart failure. BG Medicine also developed other diagnostic products and research programs involving cardiovascular and metabolic disease biomarkers.

BG Medicine was headquartered in Waltham, Massachusetts, and its products were marketed through clinical laboratory and healthcare channels in the United States and select international markets. The company’s shares later traded over the counter under the symbol BGMD. Current operating activities, leadership, and corporate status are not readily verifiable from reliable public information.

AI Generated. May Contain Errors.

Receive BGMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BG Medicine and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BGMD Stock News Headlines

BGMD Share News Today
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
BG Medicine, Inc. (BGMD)
Medicine Through Time
BGMD - BG Medicine, Inc.
Jiangsu Hengrui Medicine
See More Headlines

BGMD Stock Analysis - Frequently Asked Questions

BG Medicine Inc. (OTCMKTS:BGMD) issued its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that BG Medicine investors own include Blue Ridge Mountain Resources (MHRCQ), Athersys (ATHX), Bristol Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/17/2015
Today
10/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
OTCMKTS:BGMD
Previous Symbol
NASDAQ:BGMD
CIK
1407038
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.51
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:BGMD) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners